PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Marital status, race increase survival rate significantly for Stage III non-small cell lung cancer patients

Single men have worst 3-year survival rate at only 3 percent

2012-09-07
(Press-News.org) A study of survival data for Stage III, non-small cell lung cancer (NSCLC) patients at the University of Maryland's Greenebaum Cancer Center in Baltimore indicates that marital status and race can significantly impact patient survival rates, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC), and The University of Chicago.

This study reviewed the records of 168 patients with Stage III NSCLC who were treated with curative intent using chemotherapy and radiation at the Greenebaum Cancer Center from January 2000 to December 2010. The median survival rate for all patients was 13 months, with three-year survival rates of 21 percent.

Married women had the best three-year survival rate of 46 percent, and single men had the worst three-year survival rate of 3 percent. Married patients had improved survival compared to single patients—33 percent vs. 10 percent. Single females and married men had intermediate overall survival of 25 percent. Race also appears to play a role—married white patients had the best survival of 40 percent, and married black patients had a 26 percent three-year survival rate.

This study's results reinforce the critical role of spouses and caregivers in patient survival, and they are consistent with similar studies of other site-specific cancers, including head and neck and prostate cancer. The authors hypothesize that caregivers provide not only daily care but logistical support to help manage the treatment plan, compliance with the treatment plan and more accurate reporting of patient symptoms.

"While we were not surprised by these results, they confirm the positive impact of spousal support on patient survival," said lead author Elizabeth Nichols, MD, a resident in the department of radiation oncology at the University of Maryland Medical Center in Baltimore. "These findings also demonstrate the need for improved support of cancer patients and their spouses in order to continue to improve survival rates."

INFORMATION:

The abstract, "Marital Status is an Independent Predictor of Survival for Patients Undergoing Definitive Chemoradiation for Stage III Non-Small Cell Lung Cancer," will be presented during the Poster Viewing at 5:00 p.m., Central time on September 6, 2012. To speak with Elizabeth Nichols, MD, please call Michelle Kirkwood or Nicole Napoli on September 6-8, 2012, in the press office at the Chicago Marriott Downtown Magnificent Mile at 312-595-3188. You may send an email to michellek@astro.org or nicolen@astro.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Hispanic lung cancer patients have higher survival than non-Hispanic white patients

2012-09-07
Analysis of non-small cell lung cancer (NSCLC) patient records in the California Cancer Registry (CCR) database during the 20-year period of 1988-2008 indicates that Hispanics/Latinos with NSCLC have a higher overall survival compared to non-Hispanic white patients, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC), and The ...

Crizotinib reduces tumor size in patients with ALK positive lung cancer

2012-09-07
Crizotinib is effective in shrinking tumors in patients with anaplastic lymphoma receptor tyrosine kinase (ALK) positive non-small cell lung cancer, a cancer commonly found in people who never smoked, and should be the standard of care for advanced stages of this disease, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC) ...

National deficit outlook unchanged under Obama: UMD policy analysis

2012-09-07
COLLEGE PARK, Md. - From a public policy point of view, the national debt accumulation since President Obama took office is largely a result of policies put in place prior to his inauguration, says a new analysis by University of Maryland expert Philip Joyce. He adds that Obama's policies will make little impact in the debt over the next decade. "The best that can be said about presidential fiscal policies thus far is that they would slow the bleeding, but they neither would stop it nor would they do much to heal the patient," Joyce says. The size of the debt has been ...

Crews complete first block of North America's most advanced neutrino experiment

Crews complete first block of North Americas most advanced neutrino experiment
2012-09-07
Today, technicians in Minnesota will begin to position the first block of a detector that will be part of the largest, most advanced neutrino experiment in North America. The NuMI Off-Axis Neutrino Appearance experiment – NOvA for short – will study the properties of neutrinos, such as their masses, and investigate whether they helped give matter an edge over antimatter after both were created in equal amounts in the big bang. The experiment is on track to begin taking data in 2013. "This is a significant step toward a greater understanding of neutrinos," said Marvin ...

ORNL's newly licensed neutron detector will advance human disease research

2012-09-07
A neutron detector developed for studies focused on life science, drug discovery and materials technology has been licensed by PartTec Ltd. The Indiana-based manufacturer of radiation detection technologies is moving the technology developed at the U.S. Department of Energy's Oak Ridge National Laboratory toward the commercial marketplace. The Neutron-Sensitive Anger Camera allows researchers to study a wider variety of crystalline structures, supporting studies in biology, earth science, geology, materials science and condensed matter physics. "This ORNL detector system, ...

Favorite TV reruns may have restorative powers, says UB researcher

Favorite TV reruns may have restorative powers, says UB researcher
2012-09-07
BUFFALO, N.Y. -- We hear all the time that we need to get off the couch, stop watching TV and get moving. But what if watching TV under specific conditions could actually provide the mental boost you need to tackle a difficult task? A new paper that describes two studies by Jaye Derrick, PhD, research scientist at the University at Buffalo's Research Institute on Addictions, found that watching a rerun of a favorite TV show may help restore the drive to get things done in people who have used up their reserves of willpower or self-control. "People have a limited pool ...

September 2012 story tips

2012-09-07
ENERGY – Revolutionary heat pump . . . Oak Ridge National Laboratory and Oklahoma's ClimateMaster Inc. have collaborated to develop a ground source heat pump that can reduce a homeowner's electric bill by up to 60 percent. The Trilogy 40 is the first geothermal heat pump certified by the Air Conditioning, Heating and Refrigeration Institute to achieve a space cooling efficiency rating in excess of 40 EER (energy efficiency ratio). An EER rating of 13.5 is typical of conventional heat pumps. For a family living in a 2,600-square-foot well-insulated home, that translates ...

Even small weight gains raise blood pressure in college students

2012-09-07
URBANA – As a college student, you may be happy simply not to have gained the "Freshman 15." But a University of Illinois study shows that as little as 1.5 pounds per year is enough to raise blood pressure in that age group, and the effect was worse for young women. "In our study, a small weight gain was enough to raise a college student's systolic blood pressure by 3 to 5 points. If young people continue to gain 1.5 pounds a year and think it doesn't matter, they're misleading themselves and increasing their risk for heart disease," said Margarita Teran-Garcia, a U of ...

Alcoholics Anonymous participation promotes long-term recovery

2012-09-07
A new study published in a special issue of Substance Abuse finds that recovering alcoholics who help others in 12-step programs furthers their time sober, consideration for others, step-work, and long-term meeting attendance. These novel findings are from a 10-year, prospective investigation led by Maria Pagano, PhD, associate professor of psychiatry at Case Western Reserve University School of Medicine and principal investigator of the "Helping Others" study. Dr. Pagano and colleagues evaluated the decade long of treatment outcomes using data from a single site in ...

Modeling sepsis in newborns

2012-09-07
Boston, Mass. - Sepsis, or bacterial infection of the bloodstream, is a grave, hard-to-diagnose threat in premature newborns in the NICU. Even when it's detected and treated with antibiotics, its inflammatory effects can harm fragile babies' development. Now, researchers at Boston Children's Hospital have modeled the effects of sepsis on the unique newborn immune system, using mice. They and others have begun using the model to identify diagnostic markers and better treatments. The new model is described September 6 in the online open-access journal PLOS ONE (available ...

LAST 30 PRESS RELEASES:

ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma

Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy

Drug combo cuts risk of death in advanced prostate cancer by 40%

ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors

Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients

New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease

Sylvester Cancer Tip Sheet for October 2025

Three science and technology leaders elected to Hertz Foundation Board of Directors

Jump Trading CSO Kevin Bowers elected to Hertz Foundation Board of Directors

Former Inscripta CEO Sri Kosaraju elected to Hertz Foundation Board of Directors

Citadel’s Jordan Chetty elected to Hertz Foundation Board of Directors

McGill research flags Montreal snow dump, inactive landfills as major methane polluters

A lightweight and rapid bidirectional search algorithm

Eighty-five years of big tree history available in one place for the first time

MIT invents human brain model with six major cell types to enable personalized disease research, drug discovery

Health and economic air quality co-benefits of stringent climate policies

How immune cells deliver their deadly cargo

How the brain becomes a better listener: How focus enhances sound processing

Processed fats found in margarines unlikely to affect heart health

Scientists discover how leukemia cells evade treatment

Sandra Shi MD, MPH, named 2025 STAT Wunderkind

Treating liver disease with microscopic nanoparticles

Chemicals might be hitching a ride on nanoplastics to enter your skin

Pregnant patients with preexisting high cholesterol may have elevated CV risk

UC stroke experts discuss current and future use of AI tools in research and treatment

The Southern Ocean’s low-salinity water locked away CO2 for decades, but...

OHSU researchers develop functional eggs from human skin cells

[Press-News.org] Marital status, race increase survival rate significantly for Stage III non-small cell lung cancer patients
Single men have worst 3-year survival rate at only 3 percent